Modifications to China's COVID-19 diagnosis and treatment guidelines are aimed at relieving strains on the medical system in the face of the highly contagious Omicron variant, officials and experts said.
East China's Zhejiang province has been promoting COVID-19 booster shots since late February in response to China's new vaccination strategy aiming to reinforce herd immunity against the disease.
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.
Answers to commonly-asked questions about the Omicron variant of COVID-19.
From Nov 1, 18 medical institutes in Jinhua were designated to provide 24-hour nucleic acid testing services, in a bid to further strengthen anti-COVID-19 measures over the autumn and winter period.
Although there isn't enough evidence now to support delivering COVID-19 booster shots to the general public, China is studying whether it is necessary to give additional doses to vulnerable groups and high-risk workers in order to boost immunity, health experts said.
The Jinhua People's Hospital – located in Jinhua city in East China's Zhejiang province – was established in 1942 and it is now a comprehensive hospital integrating medical treatment, prevention, scientific research, teaching and rehabilitation.